This review identifies knowledge gaps and research to strengthen the 2014 updated guidelines of the World Health Organization (WHO) Medical Eligibility Criteria for Contraceptive Use and the WHO Selected Practice Recommendations for Contraceptive Use. The authors present three global topics in detail: intrauterine device initiation among women at high risk for sexually transmitted infections; bidirectional drug–drug interactions with use of hormonal contraception and antiretroviral therapy; and initiation of progestogen-containing contraception following use of ulipristal acetate emergency contraception.
Research gaps identified during the 2014 update of the WHO medical eligibility criteria for contraceptive use and selected practice recommendations for contraceptive use
Written By
Dragoman MV, Jatlaoui T, Nanda K, Curtis KM, Gaffield ME